 |
FDA Approval Activities for this Drug
DISOPYRAMIDE PHOSPHATE Capsule, Extended Release; 100MG BASE NORPACE CR GD SEARLE 018655 DISOPYRAMIDE PHOSPHATE Capsule, Extended Release; 150MG BASE NORPACE CR GD SEARLE 071200 DISOPYRAMIDE PHOSPHATE Capsule, Extended Release; 150MG BASE DISOPYRAMIDE PHOSPHATE KV 017447 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE NORPACE GD SEARLE 017447 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE NORPACE GD SEARLE 070470 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE Geneva 070471 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE DISOPYRAMIDE PHOSPHATE Geneva 070186 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE Ivax 070187 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE DISOPYRAMIDE PHOSPHATE Ivax 070940 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE SUPERPHARM
070101 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE Teva
070102 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE DISOPYRAMIDE PHOSPHATE Teva
070173 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE Watson 070174 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE DISOPYRAMIDE PHOSPHATE Watson
For the most up-to-date approval information, please locate this API using the drug index.
|